F
Form Bio
Empowers scientists to harness the data, computing power and collaboration that drive how breakthroughs are made
About Form Bio
Form Bio is a software platform that enables scientists to get more computational work done with less effort and in less time. It is designed to make complex tasks easier and faster, allowing users to iterate faster on datasets, workflows and results. Form Bio is different from other businesses in the same industry because it doesn't require coding, scripting or development skills, and it brings expertise from disparate fields such as artificial intelligence, bioinformatics and biology together in one cohesive experience. It also makes it easy to cite and share datasets, methodologies and findings with peers, and it enables peers and partners to deconstruct and reconstruct research. Form Bio makes a profit by providing its software platform to customers, who use it to save time and maximize their research. It is trusted by leading research institutions such as Harvard Medical School, MIT, and the University of Melbourne, and it is an indispensable tool for conservation and de-extinction research initiatives.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- San Carlos, United States
- Employees
- 36
- Open positions
- 1
- Dealroom signal
- 67.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Biotech and Pharma, AI Drug Discovery, Hard Tech, AI Applications, DT and LS, science-based
- Technology
- Artificial Intelligence
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Jan 2021
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CORPORATE SPINOUT✓Other financing | Sep 2022 | $0 | — | Colossal | ↗ |
| SERIES A✓Equity / VC | Sep 2022 | $30M | $120M | JAZZ Venture Partners · Thomas Tull · Colossal | ↗ |
Growth signals
Latest recorded traffic for Form Bio is 4.8K monthly website visits, up 26.3% over the last three months. Form Bio's team declined 12.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- JPJAZZ Venture Partners
Thomas Tull
Series B and later1 investor entered at this stage
Colossal
Other known investors3 additional known investors
Builders VC
Calm Ventures
Jonathan Swerdlin.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Form Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Form Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.